| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6890629
[patent_doc_number] => 20010007860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-12
[patent_title] => 'METHOD OF DNA VACCINATION'
[patent_app_type] => new-utility
[patent_app_number] => 09/113836
[patent_app_country] => US
[patent_app_date] => 1998-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15669
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20010007860.pdf
[firstpage_image] =>[orig_patent_app_number] => 09113836
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/113836 | METHOD OF DNA VACCINATION | Jul 9, 1998 | Abandoned |
| 09/112655 | POLYNUCLEOTIDE VACCINE FORMULATIONS | Jul 8, 1998 | Abandoned |
| 09/101226 | CELLULAR IMMUNOGENS USEFUL AS CANCER VACCINES | Jul 1, 1998 | Abandoned |
Array
(
[id] => 1231675
[patent_doc_number] => 06693086
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-17
[patent_title] => 'Systemic immune activation method using nucleic acid-lipid complexes'
[patent_app_type] => B1
[patent_app_number] => 09/104759
[patent_app_country] => US
[patent_app_date] => 1998-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 43
[patent_no_of_words] => 27625
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/693/06693086.pdf
[firstpage_image] =>[orig_patent_app_number] => 09104759
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/104759 | Systemic immune activation method using nucleic acid-lipid complexes | Jun 24, 1998 | Issued |
Array
(
[id] => 1268558
[patent_doc_number] => 06652850
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity'
[patent_app_type] => B1
[patent_app_number] => 09/000003
[patent_app_country] => US
[patent_app_date] => 1998-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 62
[patent_no_of_words] => 26471
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/652/06652850.pdf
[firstpage_image] =>[orig_patent_app_number] => 09000003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/000003 | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity | Jun 14, 1998 | Issued |
Array
(
[id] => 4286118
[patent_doc_number] => 06268214
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Vectors encoding a modified low affinity nerve growth factor receptor'
[patent_app_type] => 1
[patent_app_number] => 9/094577
[patent_app_country] => US
[patent_app_date] => 1998-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 9247
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268214.pdf
[firstpage_image] =>[orig_patent_app_number] => 094577
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/094577 | Vectors encoding a modified low affinity nerve growth factor receptor | Jun 11, 1998 | Issued |
| 08/973602 | COLORECTAL CANCER RISK FACTOR DETECTION AND TREATMENT | Jun 3, 1998 | Abandoned |
Array
(
[id] => 4103623
[patent_doc_number] => 06056952
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-02
[patent_title] => 'Selective elimination of T cells that recognize specific preselected targets'
[patent_app_type] => 1
[patent_app_number] => 9/029045
[patent_app_country] => US
[patent_app_date] => 1998-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21396
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/056/06056952.pdf
[firstpage_image] =>[orig_patent_app_number] => 029045
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/029045 | Selective elimination of T cells that recognize specific preselected targets | Jun 1, 1998 | Issued |
Array
(
[id] => 4124049
[patent_doc_number] => 06127172
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-03
[patent_title] => 'Materials and methods for delivery and expression of heterologous DNA in vertebrate cells'
[patent_app_type] => 1
[patent_app_number] => 9/086651
[patent_app_country] => US
[patent_app_date] => 1998-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2527
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/127/06127172.pdf
[firstpage_image] =>[orig_patent_app_number] => 086651
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/086651 | Materials and methods for delivery and expression of heterologous DNA in vertebrate cells | May 28, 1998 | Issued |
Array
(
[id] => 544636
[patent_doc_number] => 07163925
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-01-16
[patent_title] => 'p16 expression constructs and their application in cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 09/080935
[patent_app_country] => US
[patent_app_date] => 1998-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 18616
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/163/07163925.pdf
[firstpage_image] =>[orig_patent_app_number] => 09080935
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/080935 | p16 expression constructs and their application in cancer therapy | May 18, 1998 | Issued |
Array
(
[id] => 5875376
[patent_doc_number] => 20020049404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'FAS LIGAND EXPRESSING ANTIGEN PRESENTING CELLS FOR TOLERANCE INDUCTION'
[patent_app_type] => new
[patent_app_number] => 09/079834
[patent_app_country] => US
[patent_app_date] => 1998-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12491
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049404.pdf
[firstpage_image] =>[orig_patent_app_number] => 09079834
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/079834 | FAS LIGAND EXPRESSING ANTIGEN PRESENTING CELLS FOR TOLERANCE INDUCTION | May 14, 1998 | Abandoned |
| 09/078904 | EXPRESSION VECTORS FOR STIMULATING AN IMMUNE RESPONSE AND METHODS OF USING SAME | May 12, 1998 | Abandoned |
Array
(
[id] => 1536385
[patent_doc_number] => 06337321
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity'
[patent_app_type] => B1
[patent_app_number] => 09/075509
[patent_app_country] => US
[patent_app_date] => 1998-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13828
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337321.pdf
[firstpage_image] =>[orig_patent_app_number] => 09075509
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/075509 | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity | May 7, 1998 | Issued |
Array
(
[id] => 4295552
[patent_doc_number] => 06235968
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Metastasis models using green fluorescent protein (GFP) as a marker'
[patent_app_type] => 1
[patent_app_number] => 9/067734
[patent_app_country] => US
[patent_app_date] => 1998-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6199
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235968.pdf
[firstpage_image] =>[orig_patent_app_number] => 067734
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/067734 | Metastasis models using green fluorescent protein (GFP) as a marker | Apr 27, 1998 | Issued |
Array
(
[id] => 7636981
[patent_doc_number] => 06379674
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Use of herpes vectors for tumor therapy'
[patent_app_type] => B1
[patent_app_number] => 09/064174
[patent_app_country] => US
[patent_app_date] => 1998-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 9491
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/379/06379674.pdf
[firstpage_image] =>[orig_patent_app_number] => 09064174
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/064174 | Use of herpes vectors for tumor therapy | Apr 21, 1998 | Issued |
Array
(
[id] => 1602746
[patent_doc_number] => 06432925
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'RNA cancer vaccine and methods for its use'
[patent_app_type] => B1
[patent_app_number] => 09/061794
[patent_app_country] => US
[patent_app_date] => 1998-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8608
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432925.pdf
[firstpage_image] =>[orig_patent_app_number] => 09061794
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/061794 | RNA cancer vaccine and methods for its use | Apr 15, 1998 | Issued |
Array
(
[id] => 4364047
[patent_doc_number] => 06255555
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Transgenic mouse expressing human fusin and human CD4'
[patent_app_type] => 1
[patent_app_number] => 9/061048
[patent_app_country] => US
[patent_app_date] => 1998-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6095
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255555.pdf
[firstpage_image] =>[orig_patent_app_number] => 061048
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/061048 | Transgenic mouse expressing human fusin and human CD4 | Apr 15, 1998 | Issued |
Array
(
[id] => 4348263
[patent_doc_number] => 06284879
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Transport associated protein splice variants'
[patent_app_type] => 1
[patent_app_number] => 9/061764
[patent_app_country] => US
[patent_app_date] => 1998-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 18626
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284879.pdf
[firstpage_image] =>[orig_patent_app_number] => 061764
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/061764 | Transport associated protein splice variants | Apr 15, 1998 | Issued |
Array
(
[id] => 4237300
[patent_doc_number] => 06080576
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Vectors for gene trapping and gene activation'
[patent_app_type] => 1
[patent_app_number] => 9/057328
[patent_app_country] => US
[patent_app_date] => 1998-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 17830
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080576.pdf
[firstpage_image] =>[orig_patent_app_number] => 057328
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/057328 | Vectors for gene trapping and gene activation | Apr 7, 1998 | Issued |
Array
(
[id] => 4295539
[patent_doc_number] => 06235967
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Metastasis models using green fluorescent protein as a marker'
[patent_app_type] => 1
[patent_app_number] => 9/049544
[patent_app_country] => US
[patent_app_date] => 1998-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5084
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235967.pdf
[firstpage_image] =>[orig_patent_app_number] => 049544
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/049544 | Metastasis models using green fluorescent protein as a marker | Mar 26, 1998 | Issued |